Assembly Biosciences, Inc. (Nasdaq: ASMB) ("Assembly") announced today the pricing of an underwritten public offering of $75 million, or 5,555,555 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE